JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise

JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise

Source: 
Fierce Biotech
snippet: 

Well, let’s start with the obvious, a pattern that has been set for a good few years now: There were no M&A deals on the so-called Merger Monday that typically kick-started the J.P. Morgan Healthcare Conference of old.

In terms of M&A, if this pattern continues in the new decade, we should rename it Mundane Monday. There was a pre-JPM deal, namely the $1.1 billion buyout of dermatology biotech Dermira from Eli Lilly, but that wasn’t causing a stir.